VISTA interaction with PSGL1, a likely VISTA receptor in tumors, is effectively disrupted by K0401-020 anti-VISTA antibody

Cruzalegui, F; Loukili, N; Delfour, O; Boute, N; Thuilliez, C; Champion, T; Malissard, M; Launay, P; Chetaille, E; Passioukov, A; Corvaia, N; Ferre, P

CANCER RESEARCH, 2020; 80 (16):